VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
OSG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
OSGOctave Specialty Group, Inc.
$4.99$225M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksOSGFinancials

Octave Specialty Group, Inc. (OSG) Income Statement

30Y historyFree accessUpdated daily

Underwriting profitability remains elusive as the company reported a 148.2% combined ratio in 2025Q3, reflecting persistent operational challenges during its strategic pivot.

Income StatementBalance SheetCash FlowRatios

OSG Income Statement

Annual statement

OSG Income Statement

Octave Specialty Group, Inc. (OSG) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue320.67M251.22M235.81M124.73M53.61M247M156M496M508M616M501.93M644.58M403.39M685.69M863.27M292.64M434.13M3.9B-2.75B-4.21B1.83B1.61B1.4B1.27B958.6M946.8M891.5M533.3M457M381.7M452.9M
Revenue Growth %212.75%6.53%89.06%132.65%-78.29%58.33%-68.55%-2.36%-17.53%22.73%-59.79%-41.17%-20.57%194.99%-32.59%-88.87%241.65%34.67%-330.06%13.5%15.16%10.17%32.71%1.25%6.2%67.17%16.7%19.73%-15.72%60.43%
Cost of Goods Sold53.81M47.19M137.17M76.73M29.25M-72M225M13M-223M513M-11.49M--------------------
COGS % of Revenue-18.79%58.17%61.52%54.55%-29.15%144.23%2.62%-43.9%83.28%-2.29%--------------------
Gross Profit266.86M204.03M98.65M47.99M24.36M319M-69M483M731M103M513.42M1.41B948.97M685.69M179.64M-1.57B-285.23M1.09B-4.98B-4.61B1.68B1.35B1.23B1.13B855.35M858.81M821.26M473.5M404.3M338.15M411.92M
Gross Margin %83.22%81.21%41.83%38.48%45.45%129.15%-44.23%97.38%143.9%16.72%102.29%219.26%235.25%100%20.81%-535.4%-65.7%27.82%180.9%109.38%91.61%83.42%87.43%88.57%89.23%90.71%92.12%88.79%88.47%88.59%90.95%
Gross Profit Growth %-106.83%105.54%96.98%-92.36%562.32%-114.29%-33.93%609.71%-79.94%-48.93%38.4%281.7%111.47%-449.32%-126.29%121.79%-8.04%-374.7%24.64%9.89%8.76%31.73%-0.4%4.57%73.45%17.12%19.56%-17.91%66.23%
Operating Expenses344.81M305.04M158.49M72.22M60.07M320M371M666M457M388M408.39M903.23M455.71M139.03M436.14M316.14M467.77M360.22M637.27M536.54M468.15M323.83M223.26M-92.03M275.03M275.89M-55.23M25.5M26.8M18.45M17.12M
OpEx % of Revenue-121.42%67.21%57.9%112.05%129.55%237.82%134.27%89.96%62.99%81.36%140.13%112.97%20.28%50.52%108.03%107.75%9.24%-23.14%-12.73%25.55%20.06%15.93%-7.23%28.69%29.14%-6.2%4.78%5.86%4.83%3.78%
Selling, General & Admin217.12M191.62M129.17M66.98M56.28M111M92M58M55M121.52M113.66M00105.1M00000000000000000
SG&A % of Revenue-76.28%54.77%53.7%104.97%44.94%58.97%11.69%10.83%19.73%22.64%--15.33%-----------------
Research & Development00000000000--------------------
R&D % of Revenue-------------------------------
Other Operating Expenses4M113.42M29.33M5.23M3.79M209M279M608M402M266.48M294.73M--------------------
Operating Income-77.95M-101.01M-59.84M-24.22M-35.71M-1M-440M-183M274M-285M105.03M510.06M493.25M-256.5M-256.5M-1.88B-753M724.9M-5.62B-5.15B1.21B1.02B1B1.22B580.32M582.92M876.5M448M377.5M319.7M394.8M
Operating Margin %-24.31%-40.21%-25.38%-19.42%-66.6%-0.4%-282.05%-36.9%53.94%-46.27%20.92%79.13%122.28%-37.41%-29.71%-643.42%-173.45%18.59%204.04%122.11%66.06%63.36%71.5%95.8%60.54%61.57%98.32%84.01%82.6%83.76%87.17%
Operating Income Growth %--68.79%-147.08%32.17%-3470.6%99.77%-140.44%-166.79%196.14%-371.36%-3.41%292.3%0%86.38%-150.06%-203.88%112.9%-9.16%-525.29%18.33%2.05%-17.77%110.02%-0.45%-33.49%95.65%18.68%18.08%-19.02%74%
EBITDA-30.44M-59.06M-39.9M-18.99M-31.91M56M-382M112M382M-133M280.85M682.83M648.66M-1.4B-253.44M-1.88B-749.36M727.89M-5.62B-5.14B1.21B1.02B1B1.24B592.66M570.48M867.14M446.5M375M318.3M395.2M
EBITDA Margin %-9.49%-23.51%-16.92%-15.23%-59.53%22.67%-244.87%22.58%75.2%-21.59%55.95%105.93%160.8%-203.67%-29.36%-642.15%-172.61%18.66%203.93%122.05%66.21%63.46%71.39%97.49%61.83%60.25%97.27%83.72%82.06%83.39%87.26%
EBITDA Growth %72%-48.03%-110.09%40.49%-156.99%114.66%-441.07%-70.68%387.22%-147.36%-5.27%146.45%-451.05%86.51%-150.78%-202.95%112.96%-9.16%-524.06%18.43%2.37%-19.33%109.28%3.89%-34.21%94.21%19.07%17.81%-19.46%70.34%
D&A (Non-Cash Add-back)47.51M41.95M19.95M5.23M3.79M57M58M295M108M152M175.83M172.77M155.41M-1.14B3.07M3.73M3.65M2.98M3.16M2.69M2.87M1.55M-1.58M21.53M12.34M-12.44M-9.36M-1.5M-2.5M-1.4M400K
EBIT-65.47M-82.37M-50.47M-24.22M-35.71M189M-218M86M515M-164M229.37M626.6M620.73M2.05B-144.19M-1.75B-571.67M878.66M-5.26B-4.64B1.65B1.32B223.26M1.1B275.03M275.89M519.6M36.5M32.8M21.3M20.9M
Net Interest Income-12.48M-18.64M-9.38M0-167M-187M-222M-269M-242M-120M-124.34M-116.54M-127.48M0-112.32M-128.09M-181.33M-153.76M-362.69M-510.37M-435.2M-295.15M-223.26M-250.52M-275.03M-275.89M-37.48M-36.5M-32.8M-21.3M-20.9M
Interest Income0000000000000000000000000000000
Interest Expense12.48M18.64M9.38M0167M187M222M269M242M120M124.34M116.54M127.48M112.32M112.32M128.09M181.33M153.76M362.69M510.37M435.2M295.15M223.26M250.52M275.03M275.89M37.48M36.5M32.8M21.3M20.9M
Other Income/Expense1K00003M00-1M1M0--------------------
Pretax Income-77.95M-101.01M-59.84M-24.22M-35.71M2M-440M-183M273M-284M105.03M510.06M493.25M-249.29M-256.5M-1.88B-753M724.9M-5.62B-5.15B1.21B1.02B975.54M849.59M563.33M568.01M482.12M404.6M328.9M286M375.5M
Pretax Margin %-24.31%-40.21%-25.38%-19.42%-66.6%0.81%-282.05%-36.9%53.74%-46.1%20.92%79.13%122.28%-36.36%-29.71%-643.42%-173.45%18.59%204.04%122.11%66.06%63.36%69.6%66.78%58.77%59.99%54.08%75.87%71.97%74.93%82.91%
Income Tax-2.42M-5.21M-924K-989K-462K18M-3M32M5M44M30.71M17.36M9.56M2.85M2.85M77.42M135K-739.52M-9.21M-1.9B334.3M271.75M250.94M221.49M131.4M135.04M115.95M96.7M74.9M63M99.2M
Effective Tax Rate %3.1%5.16%1.54%4.08%1.29%900%0.68%-17.49%1.83%-15.49%29.24%3.4%1.94%-1.14%-1.11%-4.11%-0.02%-102.02%0.16%36.89%27.62%26.57%25.72%26.07%23.33%23.77%24.05%23.9%22.77%22.03%26.42%
Net Income-141.06M-240.92M-556.45M3.63M521.25M-17M-437M-216M267M-329M74.84M493.4M484.07M-252.14M-256.68M-1.96B-753.2M14.61M-5.61B-3.25B875.91M751.01M724.6M618.9M432.59M432.9M366.2M307.9M254M223M276.3M
Net Margin %-43.99%-95.9%-235.97%2.91%972.26%-6.88%-280.13%-43.55%52.56%-53.41%14.91%76.55%120%-36.77%-29.73%-669.9%-173.49%0.37%203.71%77.06%47.81%46.53%51.7%48.65%45.13%45.72%41.08%57.73%55.58%58.42%61.01%
Net Income Growth %79.7%56.7%-15420.73%-99.3%3166.17%96.11%-102.31%-180.9%181.16%-539.59%-1.93%291.99%1.77%86.91%-160.28%-5254.31%100.26%-72.69%-470.83%16.63%3.64%17.08%43.07%-0.07%18.21%18.93%21.22%13.9%-19.29%64.96%
Net Income (Continuing)-75.53M-95.8M-58.92M-23.23M-35.24M-16M-437M-215M268M-328M74.32M492.69M483.7M3.85B-259.35M-1.96B-753.14M14.62M-5.61B-3.25B875.91M751.01M724.6M618.9M431.93M432.97M366.2M307.9M254M223M276.3M
Discontinued Operations0-163.29M-497.17M28.18M557.36M00000000-4.54M00000000-1.29M-9.18M666K-65K00000
Minority Interest316.62M370.38M338.62M70.04M73M78M67M60M41.15M264.11M264.11M273.55M274.63M275.44M660.56M663.44M654.31M654.14M700M000000000000
EPS (Diluted)-3.11-5.93-11.850.1811.31-0.61-9.47-4.683.99-7.251.6410.7210.31-5.37-2.73-20.818.000.16-59.55-31.568.156.876.535.663.973.973.412.882.372.092.61
EPS Growth %75.31%49.96%-6683.33%-98.41%1954.1%93.56%-102.35%-217.29%155.03%-542.07%-3.98%291.99%-96.7%86.88%-360.13%4900%100.27%-88.69%-487.24%18.63%5.21%15.37%42.57%0%16.42%18.4%21.52%13.4%-19.92%65.19%
EPS (Basic)--5.93-11.850.1811.48-0.61-9.47-4.684.07-7.251.6610.9210.73-5.59-2.74-20.968.050.16-59.98-31.568.226.946.615.814.084.103.492.942.422.132.63
Diluted Shares Outstanding45.35M47.18M46.97M45.64M46.41M46.53M46.15M45.95M46.56M45.37M45.72M46.01M46.93M46.93M94.19M94.19M94.19M94.19M94.19M102.93M107.54M109.39M110.96M109.35M108.97M109.04M107.39M107.18M107.15M104.92M105.86M
Basic Shares Outstanding45.35M47.18M46.97M45.64M45.72M46.53M46.15M45.95M45.67M45.37M45.21M45.17M45.09M45.09M93.52M93.52M93.52M93.52M93.52M102.93M106.59M108.28M109.62M106.52M106.03M105.59M104.93M105.16M104.81M104.92M105.09M
Dividend Payout Ratio-----------------85.6%--7.98%7.83%7.03%7.23%9.3%8.3%8.8%9.55%10.47%10.85%7.78%

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Legacy liability runoff volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2025Q3)

Underwriting Profitability Remains Elusive

As reported in recent financial statements, Ambac's combined ratio reached 148.2% in 2025Q3, reflecting persistent underwriting challenges that continue to weigh on the company's bottom line as it attempts to transition toward a fee-based specialty insurance model while managing significant legacy insurance and litigation-related cost burdens.

The elevated combined ratio, consistently exceeding the 100% threshold, suggests that the company's specialty P&C and MGA segments have yet to achieve the scale necessary to offset the high fixed costs of the legacy runoff business. Investors should monitor whether the ongoing expansion of the Cirrata platform can eventually drive sufficient margin improvement to stabilize the consolidated underwriting performance.

Revenue Volatility Masks Strategic Pivot

Based on reported figures, Ambac's revenue trajectory remains highly inconsistent, with a 4.9% year-over-year decline in 2025Q3 following periods of significant fluctuation, which complicates the assessment of the company's underlying growth momentum as it shifts away from its legacy financial guarantee roots toward specialty distribution.

The erratic revenue performance appears to be driven by the lumpy nature of legacy recoveries and the nascent stage of the MGA growth engines. This lack of top-line predictability warrants further investigation into whether the current revenue mix can provide a sustainable foundation for future earnings growth or if it remains tethered to legacy volatility.

Legacy Drag Obscures Operational Reality

According to recent SEC filings, the company's net income of -$112.6 million in 2025Q3 highlights the substantial impact of legacy liabilities, which may be masking the potential economic value of the newer, capital-light MGA and specialty P&C segments that management is actively attempting to scale.

The persistent net losses suggest that the company's structural pivot is currently being undermined by the ongoing costs associated with managing its legacy financial guarantee portfolio. Analysts should remain cautious, as the ultimate success of this transition depends on the company's ability to ring-fence these legacy obligations and prevent them from continuing to erode the capital base of the growth segments.

OSG — Frequently Asked Questions

Quick answers to the most common questions about buying OSG stock.

What was Octave Specialty Group, Inc.'s (OSG) revenue in 2025?

For fiscal year 2025, Octave Specialty Group, Inc. (OSG) reported total revenue of $251.2M. This represents a 44.5% decline compared to $452.9M in 1996.

Is Octave Specialty Group, Inc. (OSG) profitable?

Octave Specialty Group, Inc. (OSG) reported a net loss of $240.9M for the fiscal year ending 2025.

What is Octave Specialty Group, Inc.'s operating profit margin?

Octave Specialty Group, Inc. (OSG) reported an operating income of $-101.0M, resulting in an operating profit margin of -40.2%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Octave Specialty Group, Inc.'s gross profit and gross margin?

Octave Specialty Group, Inc. (OSG) generated $204.0M in gross profit for the year, representing a gross profit margin of 81.2%. This demonstrates the company's core pricing power and production efficiency.